Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

US Mid-Market M&A Deal Volumes Will Materially Increase By The End Of 2023: https://www.valuewalk.com/wp-content/uploads/2022/11/Merger-and-acquisition-strategies-300x150.jpeg
US Mid-Market M&A Deal Volumes Will Materially Increase By The End Of 2023

Over 80% of respondents anticipate deal volumes will increase in the next 12 months.

CIL, the international management consultancy, has published its US Mid-Market M&A Pulse Check 2023 which is

Gov. Signs Largest Property Tax Cut In Texas History: How it Benefits You: https://www.valuewalk.com/wp-content/uploads/2023/08/Texas-300x150.jpeg
Gov. Signs Largest Property Tax Cut In Texas History: How it Benefits You

Texas Gov. Greg Abbott ceremonially signed the $18 billion property tax relief bill into law on Wednesday. The bill, which is the largest property tax cut in Texas history, will bring massive

MicroVision Announces Second Quarter 2023 Results
MicroVision Announces Second Quarter 2023 Results

REDMOND, WA / ACCESSWIRE / August 8, 2023 / MicroVision, Inc. (NASDAQ:MVIS), a leader in MEMS-based solid-state automotive lidar and ADAS solutions, today announced its second quarter 2023

MicroVision meldet Ergebnisse für das zweite Quartal 2023
MicroVision meldet Ergebnisse für das zweite Quartal 2023

Redmond, WA/ACCESSWIRE/8. August 2023/ MicroVision, Inc. (NASDAQ:MVIS), ein führender Anbieter von MEMS-basierten Festkörper-Automobil-LiDAR- und modernen Fahrerassistenzsystemen (ADAS), gab

Residential Prices, Rents Dip Across Qatar As World Cup Boost Dissipates: https://www.valuewalk.com/wp-content/uploads/2023/08/Rental-Rate-1.jpg
Residential Prices, Rents Dip Across Qatar As World Cup Boost Dissipates

Residential market declines amid supply surge, office market faces oversupply challenges, retail market competes with increasing pressure, and hotel occupancy falters despite spike in tourist

Therapie von gastrointestinalen Stromatumoren: QIAGEN erhält FDA-Zulassung für Begleitdiagnostikum zu AYVAKIT® (avapritinib) von Blueprint Medicines: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24065/Qiagen_Logo.svg.png
Therapie von gastrointestinalen Stromatumoren: QIAGEN erhält FDA-Zulassung für Begleitdiagnostikum zu AYVAKIT® (avapritinib) von Blueprint Medicines

therascreen® PDGFRA RGQ PCR-Kit von QIAGEN in USA zugelassen, um Patienten mit inoperablen oder metastasierenden gastrointestinalen Stromatumoren und PDGFRA-D842V-Mutation zu ermitteln, die für eine

Therapie von gastrointestinalen Stromatumoren: QIAGEN erhält FDA-Zulassung für Begleitdiagnostikum zu AYVAKIT® (avapritinib) von Blueprint Medicines: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24065/Qiagen_Logo.svg.png
Therapie von gastrointestinalen Stromatumoren: QIAGEN erhält FDA-Zulassung für Begleitdiagnostikum zu AYVAKIT® (avapritinib) von Blueprint Medicines

therascreen® PDGFRA RGQ PCR-Kit von QIAGEN in USA zugelassen, um Patienten mit inoperablen oder metastasierenden gastrointestinalen Stromatumoren und PDGFRA-D842V-Mutation zu ermitteln, die für eine

BioNTech veröffentlicht Ergebnisse des zweiten Quartals 2023 und Informationen zur Geschäftsentwicklunghttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
BioNTech veröffentlicht Ergebnisse des zweiten Quartals 2023 und Informationen zur Geschäftsentwicklung
  • Wichtige Fortschritte in der Weiterentwicklung der Pipeline durch den Beginn der zulassungsrelevanten Phase-3-Studie mit BNT316/ONC-392 sowie Vorbereitungen für mehrere geplante Studienstarts im
BioNTech veröffentlicht Ergebnisse des zweiten Quartals 2023 und Informationen zur Geschäftsentwicklunghttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
BioNTech veröffentlicht Ergebnisse des zweiten Quartals 2023 und Informationen zur Geschäftsentwicklung
  • Wichtige Fortschritte in der Weiterentwicklung der Pipeline durch den Beginn der zulassungsrelevanten Phase-3-Studie mit BNT316/ONC-392 sowie Vorbereitungen für mehrere geplante Studienstarts im
OKX Wallet Launches Account Abstraction-Powered ‘Smart Account’ Feature, Enabling USDT and USDC Gas Fee Payments on Multiple Chains: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
OKX Wallet Launches Account Abstraction-Powered ‘Smart Account’ Feature, Enabling USDT and USDC Gas Fee Payments on Multiple Chains

Singapore, Singapore, August 2nd, 2023, Chainwire

  • Additional account abstraction capabilities, including a social recovery feature, will be rolled out at a later date

OKX, a leading Web3

Glucose Monitor Maker DexCom In Buy Zone After Gapping Higher: https://www.valuewalk.com/wp-content/uploads/2023/06/DexCom-300x150.jpeg
Glucose Monitor Maker DexCom In Buy Zone After Gapping Higher

Glucose-monitor maker DexCom Inc. (NASDAQ:DXCM) was among the top three gainers within the healthcare sector on July 28, advancing 2.33% in the season after gapping higher at the open. 

Key

Glucose Monitor Maker DexCom In Buy Zone After Gapping Higher: https://www.valuewalk.com/wp-content/uploads/2023/06/DexCom-300x150.jpeg
Glucose Monitor Maker DexCom In Buy Zone After Gapping Higher

Glucose-monitor maker DexCom Inc. (NASDAQ:DXCM) was among the top three gainers within the healthcare sector on July 28, advancing 2.33% in the season after gapping higher at the open. 

Key

Gov. Abbott Announces $87.7M in Housing Tax Credits from Texas: https://www.valuewalk.com/wp-content/uploads/2023/01/New-Homes-300x150.jpeg
Gov. Abbott Announces $87.7M in Housing Tax Credits from Texas

Texas Governor Greg Abbott announced on Monday that the Texas Department of Housing and Community Affairs (TDHCA) had awarded almost $90 million in tax credits. These housing tax credits from Texas

Behind the Fortune: Klaus Schwab Net Worth Revealed
Behind the Fortune: Klaus Schwab Net Worth Revealed

Who is Klaus Schwab?

Klaus Schwab is a German engineer and economist. He is one of the most affluent people in the world, with an estimated net worth of between $7 million and $25 million. He

Al Gore Net Worth: Earnings from Politics to Present
Al Gore Net Worth: Earnings from Politics to Present

Albert Arnold Gore Jr. is an American politician and entrepreneur with a net worth of $300 million. Al Gore built his multi-million business empire after leaving politics. He served as the Vice

QIAGEN erweitert Angebot an digitalen PCR-Kits und -Dienstleistungen für Biopharma-Branche: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24065/Qiagen_Logo.svg.png
QIAGEN erweitert Angebot an digitalen PCR-Kits und -Dienstleistungen für Biopharma-Branche

Neue Partnerschaft mit Niba Labs ermöglicht Biopharma-Kunden Zugang zu Dienstleistungen für maßgeschneidertes digitales PCR-Testdesign // Neues CGT Viral Vector Lysis Kit bietet standardisierten

QIAGEN erweitert Angebot an digitalen PCR-Kits und -Dienstleistungen für Biopharma-Branche: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24065/Qiagen_Logo.svg.png
QIAGEN erweitert Angebot an digitalen PCR-Kits und -Dienstleistungen für Biopharma-Branche

Neue Partnerschaft mit Niba Labs ermöglicht Biopharma-Kunden Zugang zu Dienstleistungen für maßgeschneidertes digitales PCR-Testdesign // Neues CGT Viral Vector Lysis Kit bietet standardisierten

15 Of Top 20 Biopharma Companies By Revenue Report 5.2% YoY Growth In 2022: https://www.valuewalk.com/wp-content/uploads/2023/07/Biopharma-Companies.jpg
15 Of Top 20 Biopharma Companies By Revenue Report 5.2% YoY Growth In 2022

The biopharmaceutical industry had an exceptional year in 2022 with notable success for those with COVID-19 vaccines. The majority (15) of the top 20 publicly traded global innovative biopharma

15 Of Top 20 Biopharma Companies By Revenue Report 5.2% YoY Growth In 2022: https://www.valuewalk.com/wp-content/uploads/2023/07/Biopharma-Companies.jpg
15 Of Top 20 Biopharma Companies By Revenue Report 5.2% YoY Growth In 2022

The biopharmaceutical industry had an exceptional year in 2022 with notable success for those with COVID-19 vaccines. The majority (15) of the top 20 publicly traded global innovative biopharma

July 4th Is A New Thanksgiving Day – With Two Bullish Surprises: https://www.valuewalk.com/wp-content/uploads/2023/07/recession.jpg
July 4th Is A New Thanksgiving Day – With Two Bullish Surprises

For weekend reading, Gary Alexander, senior writer at Navellier & Associates, offers the following commentary:

Thanksgiving came early this year – on the Fourth of July, as we celebrated a

House, Senate Pass $18B Texas Property Tax Relief Bill: How it Benefits You: https://www.valuewalk.com/wp-content/uploads/2019/10/property_1571794223-300x205.jpg
House, Senate Pass $18B Texas Property Tax Relief Bill: How it Benefits You

Ending the month-long stalemate, the Texas House on Thursday approved the landmark property tax relief bill that was passed by the Senate a day before. The $18 billion Texas property tax relief

New Ineffective Attempts To Prevent Illegal University Racial Preferences: https://www.valuewalk.com/wp-content/uploads/2021/11/Harvard_University_1636999558-300x225.jpg
New Ineffective Attempts To Prevent Illegal University Racial Preferences

New Ineffective Attempts To Prevent Illegal University Racial Preferencesl Warnings Clearly Ineffective, But Encouraging Whistle Blowers Would Work

Universities Circumventing Ban On Racial

Pfizer Just Invested $25 Million In This Biotech: https://www.valuewalk.com/wp-content/uploads/2023/07/Caribou-Biosciences-1.jpg
Pfizer Just Invested $25 Million In This Biotech

Key Points

  • Caribou surged 45% yesterday after news broke that Pfizer invested $25 million.
  • The investment by Pfizer signals a strong confidence in Caribou’s pipeline and lead candidates.
Pfizer Just Invested $25 Million In This Biotech: https://www.valuewalk.com/wp-content/uploads/2023/07/Caribou-Biosciences-1.jpg
Pfizer Just Invested $25 Million In This Biotech

Key Points

  • Caribou surged 45% yesterday after news broke that Pfizer invested $25 million.
  • The investment by Pfizer signals a strong confidence in Caribou’s pipeline and lead candidates.
Complaint Challenging Legacy Admissions Faces Legal Problems: https://www.valuewalk.com/wp-content/uploads/2023/03/Student-Loan-Forgiveness-300x150.jpeg
Complaint Challenging Legacy Admissions Faces Legal Problems

Complaint Challenging Legacy Admissions Faces Legal Problems; Those Lacking Parental Links to Harvard Are Not a Protected Class

Ban On Racial Preferences In Admissions

WASHINGTON, D.C. (July